From the Office of the Governor

State of North CarolinaOffice of the Governor20301 Mail Service Center • Raleigh, NC 27699-0301Michael F. EasleyGovernorFebruary 26, 2007Dear Readers:Almost 25 years ago, North Carolina led the way to build a new economic engine called biotechnology. We created the world's first government-sponsored biotechnology center and began making systematic, long-term State investments in biotechnology infrastructure.Today North Carolina is the nation's third largest biotech state, with more than 350

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

State of North Carolina
Office of the Governor
20301 Mail Service Center • Raleigh, NC 27699-0301

Michael F. Easley
Governor
February 26, 2007

Dear Readers:

Almost 25 years ago, North Carolina led the way to build a new economic engine called biotechnology. We created the world's first government-sponsored biotechnology center and began making systematic, long-term State investments in biotechnology infrastructure.

Today North Carolina is the nation's third largest biotech state, with more than 350 bioscience companies employing 48,000 people and thousands more working in bioscience research labs at our world-class public and private universities.

We've come a long way since 1984, but we aspire to do even more. We're executing a statewide strategic plan, New Jobs Across North Carolina, aimed at giving us 125,000 bioscience jobs by 2023. Our strategy for developing biotechnology across our state through regional offices of the North Carolina Biotechnology Center is unique among the states.

This special publication of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Michael F. Easley

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours